CN102366545A - Preparation method for traditional Chinese medicine used for treating subconjunctival blood stasis type gastritis - Google Patents
Preparation method for traditional Chinese medicine used for treating subconjunctival blood stasis type gastritis Download PDFInfo
- Publication number
- CN102366545A CN102366545A CN2011102695105A CN201110269510A CN102366545A CN 102366545 A CN102366545 A CN 102366545A CN 2011102695105 A CN2011102695105 A CN 2011102695105A CN 201110269510 A CN201110269510 A CN 201110269510A CN 102366545 A CN102366545 A CN 102366545A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- blood stasis
- traditional chinese
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 43
- 239000008280 blood Substances 0.000 title claims abstract description 43
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 235000017788 Cydonia oblonga Nutrition 0.000 claims abstract description 7
- 241001199012 Usta Species 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 12
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 244000236931 Cydonia oblonga Species 0.000 claims description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 6
- 241000180649 Panax notoginseng Species 0.000 claims description 6
- 229940056582 human hair preparation Drugs 0.000 claims description 6
- 239000010271 massa medicata fermentata Substances 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 241001649247 Boehmeria Species 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims 1
- 208000003455 anaphylaxis Diseases 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 206010067484 Adverse reaction Diseases 0.000 abstract description 3
- 230000006838 adverse reaction Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 229960001380 cimetidine Drugs 0.000 abstract description 3
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 210000003608 fece Anatomy 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 3
- 235000014347 soups Nutrition 0.000 abstract 2
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 240000000530 Alcea rosea Species 0.000 abstract 1
- 235000017334 Alcea rosea Nutrition 0.000 abstract 1
- 235000017303 Althaea rosea Nutrition 0.000 abstract 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 241001313855 Bletilla Species 0.000 abstract 1
- 241000219357 Cactaceae Species 0.000 abstract 1
- 240000001548 Camellia japonica Species 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 241000729173 Cirsium japonicum Species 0.000 abstract 1
- 244000000626 Daucus carota Species 0.000 abstract 1
- 235000002767 Daucus carota Nutrition 0.000 abstract 1
- 244000286838 Eclipta prostrata Species 0.000 abstract 1
- 240000008620 Fagopyrum esculentum Species 0.000 abstract 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 240000001076 Osbeckia chinensis Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000399256 Pteromyini Species 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 244000189123 Rumex japonicus Species 0.000 abstract 1
- 235000005247 Rumex japonicus Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000002912 Salvia officinalis Nutrition 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 235000018597 common camellia Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000003864 humus Substances 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000002020 sage Nutrition 0.000 abstract 1
- 230000008791 toxic response Effects 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 description 26
- 210000004185 liver Anatomy 0.000 description 25
- 210000000952 spleen Anatomy 0.000 description 25
- 230000001737 promoting effect Effects 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 19
- 235000009508 confectionery Nutrition 0.000 description 19
- 230000023597 hemostasis Effects 0.000 description 17
- 210000002216 heart Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 206010012735 Diarrhoea Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 206010010774 Constipation Diseases 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 9
- 206010000087 Abdominal pain upper Diseases 0.000 description 8
- 208000007502 anemia Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 230000008673 vomiting Effects 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 7
- 208000001647 Renal Insufficiency Diseases 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 201000006370 kidney failure Diseases 0.000 description 7
- 210000002429 large intestine Anatomy 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 206010002198 Anaphylactic reaction Diseases 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 206010041349 Somnolence Diseases 0.000 description 5
- 206010047513 Vision blurred Diseases 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 208000000112 Myalgia Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000005946 Xerostomia Diseases 0.000 description 4
- 230000036783 anaphylactic response Effects 0.000 description 4
- 208000006218 bradycardia Diseases 0.000 description 4
- 230000036471 bradycardia Effects 0.000 description 4
- 206010013781 dry mouth Diseases 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 206010043554 thrombocytopenia Diseases 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 201000010000 Agranulocytosis Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000001871 Tachycardia Diseases 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 3
- 108090000340 Transaminases Proteins 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000007849 functional defect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 230000006794 tachycardia Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 208000014644 Brain disease Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010013887 Dysarthria Diseases 0.000 description 2
- 208000032274 Encephalopathy Diseases 0.000 description 2
- 206010015218 Erythema multiforme Diseases 0.000 description 2
- 206010018687 Granulocytopenia Diseases 0.000 description 2
- 208000004547 Hallucinations Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010042033 Stevens-Johnson syndrome Diseases 0.000 description 2
- 206010044223 Toxic epidermal necrolysis Diseases 0.000 description 2
- 231100000087 Toxic epidermal necrolysis Toxicity 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010048222 Xerosis Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 201000000079 gynecomastia Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 201000006334 interstitial nephritis Diseases 0.000 description 2
- 208000003243 intestinal obstruction Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 201000002364 leukopenia Diseases 0.000 description 2
- 231100001022 leukopenia Toxicity 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 231100000668 minimum lethal dose Toxicity 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000003448 neutrophilic effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229960000381 omeprazole Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000023482 precordial pain Diseases 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012373 Depressed level of consciousness Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015911 Eye burns Diseases 0.000 description 1
- 206010056325 Faecaloma Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000001287 Galactorrhea Diseases 0.000 description 1
- 206010017600 Galactorrhoea Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034308 Grand mal convulsion Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 206010019851 Hepatotoxicity Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- 208000029663 Hypophosphatemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 206010025327 Lymphopenia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000010642 Porphyrias Diseases 0.000 description 1
- 201000000660 Pyloric Stenosis Diseases 0.000 description 1
- 208000008718 Pyuria Diseases 0.000 description 1
- 208000010476 Respiratory Paralysis Diseases 0.000 description 1
- 231100000168 Stevens-Johnson syndrome Toxicity 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- KZFDVWZZYOPBQZ-UHFFFAOYSA-K bismuth;potassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KZFDVWZZYOPBQZ-UHFFFAOYSA-K 0.000 description 1
- 210000005098 blood-cerebrospinal fluid barrier Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000004209 confusion Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010013395 disorientation Diseases 0.000 description 1
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 1
- 229960001253 domperidone Drugs 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000019564 dysgeusia Nutrition 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000007686 hepatotoxicity Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 1
- 231100001023 lymphopenia Toxicity 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000001118 melena Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 229960005019 pantoprazole Drugs 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000000689 peptic esophagitis Diseases 0.000 description 1
- 208000028591 pheochromocytoma Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 229960004157 rabeprazole Drugs 0.000 description 1
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- HCJLVWUMMKIQIM-UHFFFAOYSA-M sodium;2,3,4,5,6-pentachlorophenolate Chemical compound [Na+].[O-]C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl HCJLVWUMMKIQIM-UHFFFAOYSA-M 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a preparation method for a traditional Chinese medicine used for treating subconjunctival blood stasis type gastritis, which belongs to the technical field of preparation methods for traditional Chinese medicines. At present, cimetidine is normally used for treating subconjunctival blood stasis type gastritis, but cimetidine is easy to cause some adverse reactions. A technical scheme for the invention is as follows: traditional Chinese medicines of flying squirrel feces, pseudo-ginseng, cirsium japonicum, camellia, herba cephalanoploris, osbeckia chinensis, tarragon, cactus, hairyvein agrimony, bletilla rhizome, humus flava usta, crinis ustus, rumex japonicus, marmor serpentinatum, radix boehmeriae, roots of madder, common sage herb, flower of hollyhock, yerbadetajo herb, radish seed, papaya, iris, carrot, buckwheat, medicated leaven, quince, rhizoma nelumbinis and licorice are taken and immersed in water, an obtained mixture is decocted on a slow fire, dregs are removed through filtration, and decocted soup is the medicine for treating subconjunctival blood stasis type gastritis. The invention has the following advantages: it is simple to prepare the medicine; the prepared traditional Chinese medicinal soup has a small toxic and side effect, a short treatment course and a high cure rate. According to the invention, traditional Chinese medicines are applied, and adverse reactions, anaphylactic reactions and toxic response caused by western medicines are avoided.
Description
Technical field
The present invention relates to the Chinese medicinal preparation method technical field, is a kind of Chinese medicinal preparation method of treating blood stasis stationary form gastritis more specifically.
Background technology
Treat blood stasis stationary form gastritis at present, the general employing:
1, cimetidine: 1. contraindication: anemia of pregnant woman, women breast-feeding their children's forbidding.2. careful usefulness: serious heart and respiratory system disease, chronic inflammatory disease such as systemic lupus erythematosus (sle) (SLE), encephalosis, renal function injury, hepatic insufficiency, the careful usefulness of child.3. more common untoward reaction has diarrhoea, dizziness, weak, headache and erythra etc.; The useful agents amount can cause gynaecomastia, women's galactorrhea, hyposexuality, sexual impotence, sperm count minimizing etc. when big, can pass through blood-cerebrospinal fluid barrier, has certain neurotoxicity.Accidental abalienation, the rare untoward reaction of these article has: anaphylaxis, heating, arthralgia, myalgia, granulocytopenia, thrombocytopenia, interstitial nephritis, hepatotoxicity, bradycardia, tachycardia etc.
2, ranitidine: 1. contraindication: to this medicine and other H
2Receptor antagonist allergy sufferers, anemia of pregnant woman, women breast-feeding their children, the forbidding of child below 8 years old.2. careful usefulness: liver, renal insufficiency person, acute hematoporphyria person, the careful usefulness of old people.3. can occur headache, dizzy, weak, obnubilation, mental act unusually, insomnia etc.; Mental symptoms such as disorientation, drowsiness, anxiety appear in liver, renal insufficiency person and gerontal patient after accidental the taking medicine; A small amount of generation blurred vision is arranged; Constipation, diarrhoea occur, feel sick, vomit, suffer from abdominal pain; Erythra can occur, only a few generation erythema multiforme is arranged; Rare arthralgia, myalgia; Rare anaphylactic reaction shows as rubella, vasodilation, heating, bronchospasm, hypotension, anaphylactic shock, chest pain etc.; Life-time service can cause vitamin B
12Lack, male breast is womanlike rare; Cause that renal dysfunction etc., quiet notes rear section patient fever sensation of the face sense, dizziness can occur, feel sick, perspiration and gastric irritation.4. this medicine has certain toxicity to liver, so in the administration process, should monitor the patients with hepatic changes of function.When 5. vein gave this medicine, bradycardia can appear.So should be slow during quiet notes, and should make regular check on electrocardiogram in the medication process.6. this medicine has certain inhibitory action to bone marrow, and moderate leukocyte of reversibility or granulocytopenia can take place small number of patients, and the thrombocytopenia of appearance and autoimmune hemolytic anemia are also arranged.
3, famotidine: 1. contraindication: to this medicine allergy sufferers, severe renal functional defect person, anemia of pregnant woman, women breast-feeding their children's forbidding.2. careful usefulness: drug allergy history, liver, renal insufficiency person, infant Ying Shenyong are arranged.3. can cause constipation, nausea,vomiting,diarrhea, abdominal discomfort, xerostomia, inappetence, parotitis and dysgeusia; Period in a medicine, the detection index of liver function can raise; Most headache rare has dizziness, confusion, anxiety, paraesthesia, depression, insomnia, general lassitude is unable and drowsiness etc., and rare neutrophilic granulocyte reduces and thrombocytopenia, the eosinophilia, and rare libido reduces; Rare erythra, urticaria, alopecia, acne, pruritus, xerosis cutis and flushing; Rare cardiopalmus, bradycardia, atrioventricular block, increased blood pressure, menoxenia should be monitored electrocardiogram and changed during the medication; Rare toxic epidermal necrolysis; Rare hallucination, epilepsy grand mal, medication should be noted patient's clinical manifestation; Can cause tinnitus; Musculoskeletal pain comprises muscle cramp and arthralgia; Can cause pars orbitalis edema, facial edema, conjunctival congestion, vasodilation, drug fever, urticaria and erythra etc.
4, rabeprazole: 1. contraindication: anemia of pregnant woman, women breast-feeding their children's forbidding.2. careful usefulness: anaphylaxis or other untoward reaction persons, the patient of liver dysfunction were taken place once when previously using medicine such as lansoprazole, omeprazole, pantoprazole, gerontal patient Ying Shen uses this medicine.3. visible light-sensitive property reaction, erythra, pruritus, edema, visual disorder, myalgia, rhinitis.It is thus clear that xerostomia, abdominal distention, stomachache are accidentally felt sick, vomiting, constipation, diarrhoea.Rare cardiopalmus, bradycardia, chest pain.It is thus clear that dizzy, limbs fatigue, insensitive, accidental headache, rare insomnia, sleepy, grip are low, inarticulateness, lurch.Accidental blood urea nitrogen raises, albuminuria.4. use this medicine can cause erythrocyte, lymphopenia, leukopenia or increase symptoms such as EC, neutrophilic leukocytosis.5. use this medicine can cause phenomenons such as propylhomoserin aminotransferase, Aspartic Acid aminotransferase, alkali phosphatase STB, T-CHOL rising.6. use this medicine might cover the gastric cancer symptom, so should on the basis of getting rid of malignant tumor, use this medicine.
5, atropine: 1. contraindication: to this medicine or the not anti-receptor of other Semen daturae Alkaloids, glaucoma and prostate increase person, hyperpyrexia patient, acute penta sodium pentachlorophenate poisoner, myasthenia gravis patient.2. careful usefulness: patient, patients of ulcerative colitis, cerebral lesion person, diarrhea patient, gastric ulcer patient, the fever patient Ying Shenyong of illness such as the hypomotility of heart disease patient, reflux esophagitis, stomach pyloric obstruction, esophagus and stomach, relaxation of lower esophageal sphincter.3. common constipation, the minimizing of perspiring, mouth and nose dry laryngopharynx, blurred vision, erubescence, dysuria, low, the stomach-esophageal reflux of digestive tract power.Rare intraocular pressure rising, allergic rash or herpes.Can occur the dry heating of skin mucosa, flush, tachycardia, blurred vision, of short duration eye burn feeling and twinge, photophobia, eyelid swelled etc. behind the ophthalmic administration, anaphylaxiss such as pruritus, redness, conjunctival congestion appear in the small number of patients eyelid.4. xerostomia, heart rate acceleration, pupil slightly enlarge; Blurred vision; Slurred speech, dysphoria, xerosis cutis heating, urine difficulty, enterokinesia reduce; Rapid pulse and a little less than, the serious accelerated breathing of central excitation phenomenon is deepened, and delirium, hallucination, convulsions etc. occur; Can change inhibition over to by central excitation during serious the poisoning, produce stupor and respiratory paralysis etc.The minimum lethal dose (MLD) adult is about 80 ~ 130mg, and the child is 10mg.
6, aluminium hydroxide: 1. contraindication: strong basicity digestive juice secretion deficiency or acatharsia person, fracture patient, hypophosphatemia patient such as bile, pancreatic juice are arranged and the aluminium hydroxide allergy sufferers is forbidden.2. careful usefulness: the careful usefulness of acute abdomen patient such as renal insufficiency person, prolonged constipation person, old people, appendicitis.3. can cause nausea, symptom such as vomiting, constipation.Take in a large number for a long time, can cause serious constipation, even the coproma piece causes intestinal obstruction.4. patients with renal failure is taken for a long time and can be caused encephalopathy, dementia and small cell anemia etc.
7, bismuth potassium citrate: 1. contraindication: to this medicine allergy sufferers, severe renal functional defect, anemia of pregnant woman patient's forbidding.2. careful usefulness: hepatic disfunction person, child, the careful usefulness of women breast-feeding their children.3. small number of patients can have slight headache, dizziness, insomnia etc.; Erythra can appear in individual patient; Possibly have ammonia flavor in mouthful, and tongue, feces can be dyed black, be prone to obscure mutually with tarry stool; Can occur when individual patient is taken feeling sick, symptom of digestive tract such as diarrhoea, constipation, loss of appetite, diarrhoea.4. long-term large dose oral administration possibly cause Toxicity of Kidney, causes the reversibility renal failure, and with 10 days in outbreak, should make regular check on renal function.5. the untoward reaction of the skeleton relevant osteoarthritis of bismuth encephalopathy (HIE) more commonly is a premonitory symptom with one-sided or both shoulders pain often.
8, omeprazole: 1. contraindication: to this medicine allergy sufferers, severe renal functional defect person, anemia of pregnant woman, infant patient's forbidding.2. careful usefulness: liver, renal insufficiency person, women breast-feeding their children, gerontal patient Ying Shenyong.3. common adverse reactions be diarrhoea, headache, feel sick, stomachache, flatulence and constipation, accidental serum aminotransferase increases, erythra, dizzy, drowsiness, insomnia etc.; It is thus clear that chest pain, cardiopalmus, tachycardia or slow excessively, hypertension, periphery edema.It is thus clear that microscopic pyuria, albuminuria, hematuria, frequent micturition, urinary system infection, interstitial nephritis, glucose in urine, orchiodynia.It is thus clear that hemolytic anemia.It is thus clear that erubescence, drying.Rare heliosensitivity, erythema multiforme, Stevens Johnson syndrome, toxicity epidermal necrolysis, alopecia.Rare blurred vision.Rare perspiration increases, hyponatremia, gynecomastia.Rare arthralgia, myalgia, muscular strength weaken.Rare leukopenia, thrombocytopenia, agranulocytosis and pancytopenia.
9, domperidone: 1. contraindication: pheochromocytoma patient, patient with breast cancer, mechanical intestinal obstruction patient, gastrointestinal hemorrhage patient and anemia of pregnant woman's forbidding.2. careful usefulness: infant below 1 years old, allergic constitution person, cardiac or hypokalemia patient and accept the careful usefulness of tumor patient of chemotherapy.3. accidental headache, dizziness, drowsiness, asthenia, nervousness etc., EPS, epilepsy etc., visible abdominal cramps property pain, xerostomia, diarrhoea; Use can cause the non-lactation period lactogenic than heavy dose, arrhythmia can occur, accidental evanescent eruption or pruritus.
Summary of the invention
For overcoming above-mentioned shortcoming, the objective of the invention is to invent a kind of Chinese medicinal preparation method of treating blood stasis stationary form gastritis.Gastric abscess is claimed in stomachache again, is that with upper abdomen gastral cavilty portion nearly pit of the stomach place pain often to take place be main symptom.Say like " element is asked the hexa-atomic big opinion piece of writing of just recording ": " strongly fragrant the sending out of wood, the sick epigastralgia right below the heart of the people." " Ling Shu Miraculous Pivot or Divine Axis pathogen cacosplanchnia shape " piece of writing point out: " the stomach patient, the abdomen moon is very bloated, epigastralgia right below the heart." " the pained side of medical secrets of official " say: " the foot sun is bright be the warp of stomach, and the deficiency of vital energy is contrary takes advantage of the heart and pain, and its shape abdominal distention belongs to the heart and bitterly very.The epigastralgia of meaning also." the pained gastric abscess that all is meant here.So-called epigastric oppression in treatise on Febrile Diseases, feeling soft in the abdomen while pressing, or epigastric oppression, the pain of pressing etc., the real stomach that all refers to.Saying of ancient prescription nine types of precordial pain also refers to stomachache more." medical science main story gastric abscess " also said: " the ancient prescription nine types of precordial pain ... detailed its reason.All at gastral cavilty, and do not lie in the heart in fact yet.”
Etiology and pathogenesis: ancients' cloud: " qi being the governor of blood, blood being the material foundation of QI." stagnation of QI with the passing of time, then cause stopping in the blood stasis, feed touches its stasis of blood, and sends out primary disease.
Clinical manifestation: gastralgia, localized pain and tenderness, or pain has prickling sensation, postprandial pain very or see that haematemesis is just black, and the body of the tongue purple is dim, hesitant pulse.
Its technical scheme is: get Oletum Trogopterori 9 weight portions, Radix Notoginseng 6 weight portions, Radix Cirsii Japonici 9 weight portions, Flos Camelliae Japonicae 6 weight portions, Herba Cirsii 6 weight portions, Herba Osbeckiae 3 weight portions, Folium Artemisiae Argyi 6 weight portions, Radix et Caulis Opuntiae Dillenii 9 weight portions, Herba Agrimoniae 9 weight portions, Pseudobulbus Bletillae (Rhizoma Bletillae) 6 weight portions, Terra Flava Usta 9 weight portions, Crinis Carbonisatus 3 weight portions, Radix Rumicis Japonici 3 weight portions, Ophicalcitum 6 weight portion 、 Radix Boehmeriaes 9 weight portions, Radix Rubiae 9 weight portions, Herba Salviae Plebeiae 9 weight portions, Flos althaeae roseae 6 weight portions, Herba Ecliptae 6 weight portions, Semen Raphani 12 weight portions, Fructus Caricae 3 weight portions, Rhizoma Iridis Tectori 9 weight portions, Radix Dauci Sativae 12 weight portions, Semen Fagopyri Esculenti 12 weight portions, Massa Medicata Fermentata 9 weight portion 、 Cydonia oblonga 12 weight portions, Nodus Nelumbinis Rhizomatis 9 weight portions and Radix Glycyrrhizae 9 weight portions; Above 28 flavor Chinese medicines are put into 1500 ml waters; Soaked 35 minutes; Slow fire is fried 30 minutes then; Filter and remove residue; Boil medicine altogether 330 milliliters of liquid, fried medicinal liquid is the Chinese medicine of treatment blood stasis stationary form gastritis.
The advantage of this invention is: we's 28 flavor Chinese medicines, all can buy in pharmacy, and to make simply, the herb liquid toxic and side effects of processing is little, short treating period, cure rate is high.Monarch, just right.When using Chinese medicine, untoward reaction, anaphylaxis and the toxic reaction of having avoided Western medicine to cause.
Oletum Trogopterori, Radix Notoginseng, Radix Cirsii Japonici, Flos Camelliae Japonicae, Herba Cirsii, Herba Osbeckiae, Folium Artemisiae Argyi, Radix et Caulis Opuntiae Dillenii, Herba Agrimoniae, Pseudobulbus Bletillae (Rhizoma Bletillae), Terra Flava Usta, Crinis Carbonisatus, Radix Rumicis Japonici, Ophicalcitum 、 Radix Boehmeriae, Radix Rubiae, Herba Salviae Plebeiae, Flos althaeae roseae, Herba Ecliptae; More than 19 flavor medical instruments the effect of promoting blood circulation and hemostasis, spleen invigorating removing food stagnancy, promoting blood circulation and detumescence, eliminating stasis to stop pain, dispersing cold for relieving pain, stomach function regulating preventing or arresting vomiting is arranged; In the process of treatment blood stasis stationary form gastritis; Play main therapeutical effect, so be monarch drug.Semen Raphani, Fructus Caricae, Rhizoma Iridis Tectori, Radix Dauci Sativae, Semen Fagopyri Esculenti, Massa Medicata Fermentata 、 Cydonia oblonga, more than 7 flavor medical instruments invigorating the spleen and regulating the stomach is arranged, the effect of the removing food stagnancy that whets the appetite, the pain relieving that helps digestion.Can bring into play therapeutical effect by auxiliary principal agent, so be ministerial drug.The Radix Aucklandiae: hot, bitter, temperature.Go into spleen, stomach, large intestine, tri-jiao channel.Promoting the circulation of QI to relieve pain, invigorating the stomach and promoting digestion.The through focus of all medicines of energy rate is so be adjuvant drug.Radix Glycyrrhizae: sweet, flat.Go into 12 warps.The spleen reinforcing lung moistening, Yiqi and vein recovery, relieving spasm to stop pain, heat-clearing and toxic substances removing, the mediation property of medicine.The bias of all medicines can be entangled, the toxicity of all medicines can be alleviated again, so be messenger drug.Oletum Trogopterori, Radix Notoginseng, Radix Cirsii Japonici, Flos Camelliae Japonicae, Herba Cirsii, Herba Osbeckiae, Folium Artemisiae Argyi, Radix et Caulis Opuntiae Dillenii, Herba Agrimoniae, Pseudobulbus Bletillae (Rhizoma Bletillae), Terra Flava Usta, Crinis Carbonisatus, Radix Rumicis Japonici, Ophicalcitum 、 Radix Boehmeriae, Radix Rubiae, Herba Salviae Plebeiae, Flos althaeae roseae, Herba Ecliptae, Semen Raphani, Fructus Caricae, Rhizoma Iridis Tectori, Radix Dauci Sativae, Semen Fagopyri Esculenti, Massa Medicata Fermentata 、 Cydonia oblonga, Nodus Nelumbinis Rhizomatis, Radix Glycyrrhizae.This 28 flavor medicine compatibility is used, and plays the effect of removing blood stasis to reduce swelling, clearing away heat and eliminating dampness, dispersing cold for relieving pain, stomach function regulating preventing or arresting vomiting, invigorating the spleen and regulating the stomach, appetizing removing food stagnancy, the pain relieving that helps digestion jointly.Monarch, compatibility is proper, is the optimum formula of treatment blood stasis stationary form gastritis.Oletum Trogopterori: bitter, sweet, temperature.Go into liver, spleen channel.Eliminating stasis to stop pain, promoting blood circulation and hemostasis, detoxifcation, spleen invigorating removing food stagnancy.Radix Notoginseng: sweet, little hardship, temperature, nontoxic.Go into liver, stomach, large intestine channel.Hemostasis dissipating blood stasis, promoting blood circulation and detumescence, eliminating stasis to stop pain.Radix Cirsii Japonici: sweet, bitter, cold.Go into the heart, Liver Channel.Cooling blood for hemostasis, removing blood stasis to reduce swelling.Flos Camelliae Japonicae: sweet, bitter, hot, cold.Go into liver, lung, large intestine channel.Skin ulcer is treated in cooling blood for hemostasis, blood circulation promoting and blood stasis dispelling, detoxifcation.Herba Cirsii: sweet, little hardship, cold.Go into liver, spleen, urinary bladder channel.Cooling blood for hemostasis, promoting blood circulation and detoxication, inducing diuresis for treating stranguria syndrome.Herba Osbeckiae: suffering, flat.Go into lung, large intestine, Liver Channel.The hemostasis repercussive, clearing away heat and eliminating dampness, relieving cough and asthma, blood stasis dispelling dispels the wind.Folium Artemisiae Argyi: hot, bitter, temperature.Go into the liver,spleen,kidney warp.Warming the meridian for stopping bleeding, dispersing cold for relieving pain, regulating menstruation are antiabortive, removing damp to relieve itching, dredge the meridian passage.Radix et Caulis Opuntiae Dillenii: hardship, cold.Go into the heart, lung, stomach warp.Promoting flow of QI and blood, heat-clearing and toxic substances removing, evacuation of pus granulation promoting, cooling blood for hemostasis, clearing away lung-heat to relieve cough.Herba Agrimoniae: bitter, puckery, little sweet, flat.Go into lung, liver, spleen, large intestine channel.Astringing to arrest bleeding, tonify deficiency dysentery relieving, parasite killing detoxifcation, preventing the attack (or recurrence) of malaria, promoting blood circulation and detumescence.Pseudobulbus Bletillae (Rhizoma Bletillae): bitter, sweet, puckery, be slightly cold.Go into lung, liver, stomach warp.Astringing to arrest bleeding, swollen clearly granulation promoting, parasite killing are held back skin ulcer.Terra Flava Usta: suffering, tepor.Go into spleen, stomach, Liver Channel.Warming middle-JIAO hemostasis, stomach function regulating preventing or arresting vomiting, warming the spleen astringing intestine to stop diarrhea.Crinis Carbonisatus: hardship, flat.Go into liver, stomach warp.Hemostasis dissipating blood stasis, nourishing YIN diuresis, promoting tissue regeneration and ulcer healing.Radix Rumicis Japonici: hardship, cold, mild toxicity.Go into spleen, liver, large intestine, urinary bladder channel.Cooling blood for hemostasis, parasite killing are treated tinea, expelling pathogenic heat to loosen the bowels.Ophicalcitum: sour, puckery, flat.Go into Liver Channel.Astringing to arrest bleeding, hemostasis by removing blood stasis.Radix Boehmeriae: sweet, cold.Go into the heart, Liver Channel.Cooling blood for hemostasis, heat-clearing and toxic substances removing, clearing heat and preventing abortion, clearing away heat and promoting diuresis.Radix Rubiae: bitter, salty, sour, cold.Go into liver, the heart, spleen, stomach, lung meridian.Cooling blood for hemostasis, blood circulation promoting and blood stasis dispelling, dispelling wind collateral dredging, heat clearing away jaundice eliminating, eliminating phlegm and stopping cough.Herba Salviae Plebeiae: hot, bitter, cold.Go into the heart, liver, kidney channel.Cooling blood for hemostasis, inducing diuresis to remove edema, detoxifcation parasite killing.Flos althaeae roseae: sweet, salty, cold, nontoxic.Go into spleen, stomach, kidney channel.Promoting blood circulation and hemostasis, clearing away heat-damp and promoting diuresis, moistening dryness for relaxing bowels, detoxicating and resolving stagnation of pathogens.Herba Ecliptae: sweet, sour, cold.Go into liver, kidney, stomach, large and small intestinal warp.Cooling blood for hemostasis, yin nourishing black hair, removing dampness to relieve itching.Semen Raphani: hot, sweet, flat.Go into spleen, stomach warp.Promoting digestion and removing stagnation, lowering the adverse-rising QI to relieve dyspnea, expectorant antitussive.Fructus Caricae: sweet, flat.Go into spleen, stomach warp.The pain relieving that helps digestion, the row water conservancy is wet.Rhizoma Iridis Tectori: hot, bitter, cold, poisonous.Go into lung, liver, spleen channel.Promoting digestion and removing stagnation, blood circulation promoting and blood stasis dispelling, line water detumescence, heat-clearing and toxic substances removing, suppressing the hyperactive liver are only dizzy.Radix Dauci Sativae: sweet, hot, flat.Go into lung, spleen, stomach, kidney channel.Invigorating the spleen and regulating the stomach, relieving dyspepsia, warming the kidney to invigorate YANG, detoxifcation rash, nourishing the lung to arrest cough.Semen Fagopyri Esculenti: sweet, acid, cold.Go into spleen, stomach, large intestine channel.The appetizing removing food stagnancy, skin ulcer is treated in detoxifcation.Massa Medicata Fermentata: sweet, suffering, temperature.Go into spleen, stomach warp.The treatment diseases caused by exogenous pathogenic factor are got ill from overeating, dyspeptic vomiting and diarrhea, insufficiency of the spleen distension, galactopoiesis in puerperal, removing food stagnancy dysentery relieving, therapeutic method to keep the adverse QI flowing downwards expectorant.Cydonia oblonga: hot, acid, sweet, temperature.Go into spleen, stomach warp.The therapeutic method to keep the adverse QI flowing downwards helps digestion, and deodorization is relieved the effect of alcohol.Nodus Nelumbinis Rhizomatis: sweet, puckery, flat.Go into liver, lung, stomach warp.Astringing to arrest bleeding, removing heat from blood nourish blood.Radix Glycyrrhizae: sweet, flat.Go into 12 warps.The spleen reinforcing lung moistening, Yiqi and vein recovery, relieving spasm to stop pain, heat-clearing and toxic substances removing, the mediation property of medicine.
The specific embodiment
Get Oletum Trogopterori 9g, Radix Notoginseng 6g, Radix Cirsii Japonici 9g, Flos Camelliae Japonicae 6g, Herba Cirsii 6g, Herba Osbeckiae 3g, Folium Artemisiae Argyi 6g, Radix et Caulis Opuntiae Dillenii 9g, Herba Agrimoniae 9g, Pseudobulbus Bletillae (Rhizoma Bletillae) 6g, Terra Flava Usta 9g, Crinis Carbonisatus 3g, Radix Rumicis Japonici 3g, Ophicalcitum 6g 、 Radix Boehmeriae 9g, Radix Rubiae 9g, Herba Salviae Plebeiae 9g, Flos althaeae roseae 6g, Herba Ecliptae 6g, Semen Raphani 12g, Fructus Caricae 3g, Rhizoma Iridis Tectori 9g, Radix Dauci Sativae 12g, Semen Fagopyri Esculenti 12g, Massa Medicata Fermentata 9g 、 Cydonia oblonga 12g, Nodus Nelumbinis Rhizomatis 9g and Radix Glycyrrhizae 9g; More than 28 the flavor medicines put into 1500 ml waters together; Soaked 35 minutes; Slow fire is fried 30 minutes then; Filter and remove residue, fried medicinal liquid are the Chinese medicine of treatment blood stasis stationary form gastritis.Boil medicine altogether 330 milliliters of liquid, when the patient of blood stasis stationary form gastritis need treat, making fluid temperature was 35 ℃, each 110 milliliters, oral, every day three times, two is a course of treatment, if symptom is still deposited, obeys for second course of treatment again, so that recovery from illness.
Among the 378 routine blood stasis stationary form gastritis sufferers, male's 226 examples account for 59.8%; Women's 152 examples account for 40.2%.The male is more than the women.
Information slip before and after table four, 378 routine blood stasis stationary form gastritis sufferers treat
Claims (1)
1. Chinese medicinal preparation method of treating blood stasis stationary form gastritis; It is characterized in that: get Oletum Trogopterori 9 gram, Radix Notoginseng 6 grams, Radix Cirsii Japonici 9 grams, Flos Camelliae Japonicae 6 grams, Herba Cirsii 6 grams, Herba Osbeckiae 3 grams, Folium Artemisiae Argyi 6 grams, Radix et Caulis Opuntiae Dillenii 9 grams, Herba Agrimoniae 9 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 6 grams, Terra Flava Usta 9 grams, Crinis Carbonisatus 3 grams, Radix Rumicis Japonici 3 grams, Ophicalcitum 6 Ke 、 Radix Boehmeriaes 9 grams, Radix Rubiae 9 grams, Herba Salviae Plebeiae 9 grams, Flos althaeae roseae 6 grams, Herba Ecliptae 6 grams, Semen Raphani 12 grams, Fructus Caricae 3 grams, Rhizoma Iridis Tectori 9 grams, Radix Dauci Sativae 12 grams, Semen Fagopyri Esculenti 12 grams, Massa Medicata Fermentata 9 Ke 、 Cydonia oblonga 12 grams, Nodus Nelumbinis Rhizomatis 9 grams and Radix Glycyrrhizae 9 gram; Above 28 flavor Chinese medicines are put into 1500 ml waters; Soaked 35 minutes; Slow fire is fried 30 minutes then; Filter and remove residue, 330 milliliters of the liquid of boiling medicine altogether, fried medicinal liquid are the Chinese medicine of treatment blood stasis stationary form gastritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102695105A CN102366545B (en) | 2011-09-13 | 2011-09-13 | Preparation method for traditional Chinese medicine used for treating subconjunctival blood stasis type gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102695105A CN102366545B (en) | 2011-09-13 | 2011-09-13 | Preparation method for traditional Chinese medicine used for treating subconjunctival blood stasis type gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102366545A true CN102366545A (en) | 2012-03-07 |
| CN102366545B CN102366545B (en) | 2013-02-13 |
Family
ID=45759165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102695105A Expired - Fee Related CN102366545B (en) | 2011-09-13 | 2011-09-13 | Preparation method for traditional Chinese medicine used for treating subconjunctival blood stasis type gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102366545B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110820A (en) * | 2013-02-14 | 2013-05-22 | 张华� | Preparation method of traditional Chinese medicine for treating blood stasis stagnation type hypochondriac pain |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1125111A (en) * | 1994-09-29 | 1996-06-26 | 林万杰 | Chinese proprietary medicine for curing stomach trouble, duodenal ulcer and chronic gastritis |
| CN1428150A (en) * | 2000-05-18 | 2003-07-09 | 彭勇军 | Tooth-protecting product 3 |
| CN101433660A (en) * | 2007-11-12 | 2009-05-20 | 贺宇 | Pure Chinese medicine for treating ulcer bleeding |
-
2011
- 2011-09-13 CN CN2011102695105A patent/CN102366545B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1125111A (en) * | 1994-09-29 | 1996-06-26 | 林万杰 | Chinese proprietary medicine for curing stomach trouble, duodenal ulcer and chronic gastritis |
| CN1428150A (en) * | 2000-05-18 | 2003-07-09 | 彭勇军 | Tooth-protecting product 3 |
| CN101433660A (en) * | 2007-11-12 | 2009-05-20 | 贺宇 | Pure Chinese medicine for treating ulcer bleeding |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103110820A (en) * | 2013-02-14 | 2013-05-22 | 张华� | Preparation method of traditional Chinese medicine for treating blood stasis stagnation type hypochondriac pain |
| CN103110820B (en) * | 2013-02-14 | 2014-01-22 | 张祥钰 | Preparation method of traditional Chinese medicine for treating blood stasis stagnation type hypochondriac pain |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102366545B (en) | 2013-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102366615B (en) | Preparation method of traditional Chinese medicine used for treating gastritis caused by insufficiency of spleen-yang | |
| CN103263584A (en) | Preparation method of traditional Chinese medicine for treating scanty-dark-urine-type cardia inflammation | |
| CN103251809A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by thirst | |
| CN103110896B (en) | Preparation method of traditional Chinese medicine for treating blood stasis type reflux oesophagitis | |
| CN103251808A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by addiction to high-calorie food | |
| CN103251810A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by heat toxins | |
| CN103230536A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation caused by overdrinking hot tea | |
| CN102366525B (en) | Method for preparing traditional Chinese medicine for treating liver-qi attacking stomach type gastritis | |
| CN103239599A (en) | Preparation method of traditional Chinese medicine for treating pharyngalgia-type cardia inflammation | |
| CN102366614B (en) | Preparation method of traditional Chinese medicine for treating pathogenic cold stomach invading type gastritis | |
| CN103251774A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by addiction to mustard | |
| CN103251780A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by blood heat | |
| CN103110840B (en) | Preparation method of traditional Chinese medicine for treating pharyngalgia type reflux esophagitis | |
| CN102366592B (en) | Preparation method of traditional Chinese medicine for treatment of diet stagnation type gastritis | |
| CN103230504A (en) | Preparation method of traditional Chinese medicine for treating food-intake pain-type cardia inflammation | |
| CN103251807A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by pathogenic fire derived from depression of liver | |
| CN103251836A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by addiction to green onions | |
| CN103251783A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation induced by fever | |
| CN103239645A (en) | Preparation method of traditional Chinese medicine for treating cardia inflammation caused by excessive drinking | |
| CN103120770B (en) | Preparation method of traditional Chinese medicine for treating constipation-predominant reflux esophagitis | |
| CN103110821B (en) | Preparation method of traditional Chinese medicine for treating chili eating type reflux oesophagitis | |
| CN102366549B (en) | Preparation method of traditional Chinese medicine used for treating gastritis caused by deficiency of stomach-yin | |
| CN102366524B (en) | Preparation method of traditional Chinese medicine used for treating gastritis caused by stagnation-heat in liver and stomach | |
| CN102366545B (en) | Preparation method for traditional Chinese medicine used for treating subconjunctival blood stasis type gastritis | |
| CN103110898A (en) | Preparation method of traditional Chinese medicine for treating heat toxicity type reflux oesophagitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG HUI Free format text: FORMER OWNER: MENG DEQIN Effective date: 20130106 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Hui Inventor before: Meng Deqin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: MENG DEQIN TO: ZHANG HUI Free format text: CORRECT: ADDRESS; FROM: 250200 JINAN, SHANDONG PROVINCE TO: 273500 JINING, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20130106 Address after: Department of Gastroenterology, Yankuang Group General Hospital of the 273500 Shandong city of Jining province Zoucheng City Applicant after: Zhang Hui Address before: 250200 Zhangqiu people's Hospital, Ji'nan, Shandong Applicant before: Meng Deqin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130213 Termination date: 20130913 |